Chemoinformaics analysis of 12A-HYDROXYROTENONE
| Molecular Weight | 410.422 | nRot | 3 |
| Heavy Atom Molecular Weight | 388.246 | nRig | 27 |
| Exact Molecular Weight | 410.137 | nRing | 5 |
| Solubility: LogS | -4.88 | nHRing | 3 |
| Solubility: LogP | 3.598 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 58.6934 |
| nHD | 1 | BPOL | 31.6186 |
| QED | 0.779 |
| Synth | 4.023 |
| Natural Product Likeliness | 2.181 |
| NR-PPAR-gamma | 0.818 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.617 |
| Pgp-sub | 0.001 |
| HIA | 0.014 |
| CACO-2 | -4.831 |
| MDCK | 0.0000247 |
| BBB | 0.211 |
| PPB | 0.917187 |
| VDSS | 0.888 |
| FU | 0.0797626 |
| CYP1A2-inh | 0.077 |
| CYP1A2-sub | 0.884 |
| CYP2c19-inh | 0.52 |
| CYP2c19-sub | 0.869 |
| CYP2c9-inh | 0.355 |
| CYP2c9-sub | 0.838 |
| CYP2d6-inh | 0.11 |
| CYP2d6-sub | 0.914 |
| CYP3a4-inh | 0.659 |
| CYP3a4-sub | 0.876 |
| CL | 6.208 |
| T12 | 0.105 |
| hERG | 0.082 |
| Ames | 0.347 |
| ROA | 0.776 |
| SkinSen | 0.428 |
| Carcinogencity | 0.688 |
| EI | 0.02 |
| Respiratory | 0.722 |
| NR-Aromatase | 0.663 |
| Antiviral | Yes |
| Prediction | 0.722911 |